Navelbine and disease progression Patient Reports February 11, 2012

Navelbine Side Effects Report #4694651-7
Navelbine side effect was reported by a Physician from on May 29, 2003. Male patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Navelbine. After drug was administered, patient experienced the following side effects: anorexia, asthenia, chest pain , choking , constipation , cough, cyanosis, disease progression, dyspnoea exacerbated. Navelbine dosage: 25MGM2 PER DAY. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient died on 05/12/2003.

Navelbine Side Effects Report #4649081-0
Navelbine side effect was reported by a Health Professional from on Dec 21, 2004. Female patient, 57 years of age, was diagnosed with non-small cell lung cancer, pain prophylaxis and was treated with Navelbine. After drug was administered, patient experienced the following side effects: disease progression, dry skin, dyspnoea, feeling abnormal, malaise, mobility decreased, pain , pain of skin. Navelbine dosage: unknown. During the same period patient was treated with ORAMORPH. Patient died.

Navelbine Side Effects Report #4641489-2
Navelbine side effect was reported by a Physician from on Apr 19, 2005. Female patient, 54 years of age, weighting 136.7 lb, was diagnosed with metastases to central nervous system and was treated with Navelbine. After drug was administered, patient experienced the following side effects: abasia, asthenia, disease progression, fall , liver function test abnormal, lung abscess, productive cough, pulmonary haemorrhage. Navelbine dosage: 30MGM2 CYCLIC. During the same period patient was treated with TEMOZOLOMIDE. Patient was hospitalized. Patient died on 04/01/2005.

Navelbine Side Effects Report #5244837-8
Navelbine side effect was reported by a Consumer or non-health professional from SINGAPORE on Jan 03, 2007. Male patient, 73 years of age, was diagnosed with lung adenocarcinoma and was treated with Navelbine. After drug was administered, patient experienced the following side effects: asthenia, cerebral infarction, disease progression, dyspnoea, pain . Navelbine dosage: 40 MG; IV. During the same period patient was treated with CISPLATIN. Patient died on 09/18/2006.


Navelbine Side Effects Report #5528997-7
Navelbine side effect was reported by a Consumer or non-health professional from ITALY on Oct 29, 2007. Female patient, 76 years of age, was diagnosed with breast cancer metastatic and was treated with Navelbine. After drug was administered, patient experienced the following side effects: anaemia, disease progression, haematotoxicity, thrombocytopenia, transient ischaemic attack. Navelbine dosage: 50 MG/M2 IV. During the same period patient was treated with GEMCITABINE. Patient recovered.

Navelbine Side Effects Report #4622840-6
Navelbine side effect was reported by a Physician from on Mar 08, 2005. Female patient was diagnosed with breast cancer metastatic and was treated with Navelbine. After drug was administered, patient experienced the following side effects: blood bilirubin increased, coma hepatic, disease progression, jaundice , performance status decreased, transaminases increased. Navelbine dosage: 36MGM2 CYCLIC. During the same period patient was treated with GEMCITABINE. Patient died on 02/16/2005.

Navelbine Side Effects Report #6111499-7
Navelbine side effect was reported by a Physician from FRANCE on Feb 26, 2009. Female patient, 69 years of age, was diagnosed with breast cancer  and was treated with Navelbine. After drug was administered, patient experienced the following side effects: bone disorder, disease progression, hypercalcaemia. Navelbine dosage: 40 MG IV. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #4694657-8
Navelbine side effect was reported by a Health Professional from on May 31, 2005. Female patient, 64 years of age, was diagnosed with breast cancer  and was treated with Navelbine. After drug was administered, patient experienced the following side effects: abdominal pain , asthenia, disease progression, neutropenia. Navelbine dosage: 49.8MG CYCLIC. During the same period patient was treated with PANTECTA, TRANKIMAZIN, SEGURIL, IBUPROFEN, AREMIS. Patient was hospitalized. Patient died on 11/08/2004.

Navelbine Side Effects Report #4907150-1
Navelbine side effect was reported by a Health Professional from JAPAN on Dec 02, 2005. Female patient, 63 years of age, was diagnosed with breast cancer  and was treated with Navelbine. After drug was administered, patient experienced the following side effects: abdominal distension, disease progression, dysuria, urinary retention. Navelbine dosage: unknown. Patient was hospitalized. Patient recovered.


Navelbine Side Effects Report #5528884-4
Navelbine side effect was reported by a Consumer or non-health professional from FRANCE on Oct 26, 2007. Female patient, 35 years of age, was diagnosed with breast cancer  and was treated with Navelbine. After drug was administered, patient experienced the following side effects: anaemia, disease progression. Navelbine dosage: 60 MG/M2 IV. During the same period patient was treated with FLUOROURACIL, DOXORUBICIN, CYCLOPHOSPHAMIDE. Patient recovered.

Navelbine Side Effects Report #5941088-6
Navelbine side effect was reported by a Consumer or non-health professional from CZECH REPUBLIC on Oct 17, 2008. Female patient, 32 years of age, was diagnosed with breast cancer  and was treated with Navelbine. After drug was administered, patient experienced the following side effects: abdominal pain upper, dehydration, disease progression, dyspnoea, vomiting. Navelbine dosage: 40 MG/M2 IV. Patient was hospitalized. Patient recovered.